# Glow

> Three-peptide single-vial regenerative blend.

Canonical PDP: https://aurex.bio/products/glow
Research-data API: https://aurex.bio/api/research-data/glow

## Catalog facts
- Name: Glow
- SKU: `BBG70`
- Category: healing
- Dosage: 70mg
- Vials per kit: 1
- Total mass: 70mg
- Half-life: varies — composite stack
- Reconstitution: 3ml bacteriostatic water per vial

## Pricing
- One-time: $95 (MSRP $129.97 · list $109.97)
- Subscribe & save: $85.50
- Stack-tier floor (3+ vials in cart): $76
- Crypto checkout (BTC, ETH, USDC, USDT, LTC): -8% across cart
- Free tracked US shipping at $200+ subtotal, otherwise $18 flat

## Stock
- Current: 10 vials

## Pitch
Aurex aesthetic + recovery blend — one lyophilized vial. BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg co-formulated and lyophilized together for combined tissue regeneration and dermal collagen pathway research.

## Mechanism
GLOW is a research-grade blend of Tirzepatide (dual GLP-1/GIP agonist, 5 mg/mL) + Retatrutide (triple GLP-1/GIP/glucagon agonist, 4 mg/mL). The combination spans the full incretin-receptor axis plus glucagon-receptor signaling, with characterized bias profiles distinct from either compound alone in cAMP-accumulation panels.

## Common in-vitro applications
### Multi-receptor incretin signaling
Simultaneous GLP-1R / GIPR / GCGR cAMP profiling in CHO cells stably expressing each receptor.
Working range: `pM to nM range`

### Hepatic glucagon-axis activation
GCGR-mediated cAMP + downstream gluconeogenic gene expression in HepG2 cells.
Working range: `10 nM to 1 µM`

### Comparative bias profiling
β-arrestin vs G-protein recruitment ratios across the receptor panel — blend vs single-agonist baselines.
Working range: `nM range`

## Researchers commonly co-treat with
- **Tirzepatide (mono)** — Dual-agonist baseline for separating GIP-arm vs glucagon-arm contributions.
- **Retatrutide (mono)** — Triple-agonist baseline — already in the Aurex catalog as standalone SKU.
- **KLOW** — Sister blend (sema + cagri) with amylin-pathway addition — full Aurex blend comparator series.

## Storage and handling
- Lyophilized: −20°C or below, desiccated
- Reconstituted: 2–8°C, use within 30 days
- Light + air: Protect from light and air
- Solubility: Soluble in bacteriostatic water (0.9% benzyl alcohol)

## Selected peer-reviewed citations
- Coskun T, et al. (2018). LY3298176, a novel dual GIP and GLP-1 receptor agonist (Tirzepatide). *Molecular Metabolism*.
- Coskun T, et al. (2022). LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist (Retatrutide). *Cell Metabolism*.
- Jastreboff AM, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity. *New England Journal of Medicine*.

## Verification
- Independently re-tested at Janoshik Analytical (HPLC-UV at 214 nm + ESI mass spectrometry).
- 100% purity-replacement guarantee: any batch failing an independent retest gets reshipped free.
- Per-batch QR code on the outer kit card resolves to https://aurex.bio/research/batch/[id].

## Compliance
Aurex is a chemical supplier and is **not** a compounding pharmacy or an outsourcing facility as defined under the Federal Food, Drug, and Cosmetic Act. Aurex products are not pharmaceuticals, food additives, or dietary supplements. Aurex does not provide dosage or use guidance — Federal regulations governing research-chemical distribution prohibit it. Distributed strictly for in-vitro laboratory research by qualified researchers 21+. Not for human or veterinary use. Not FDA approved.

---
Wiki: https://aurex.bio/wiki · API: https://aurex.bio/api · Bot: https://t.me/Aurex33bot
Generated 2026-05-04